Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma
==========================================================================================================================================

* Yang Liu
* Chunmeng Wang
* Xiang Li
* Liang Dong
* Qingming Yang
* Meixia Chen
* Fengxia Shi
* Malcolm Brock
* Miao Liu
* Qian Mei
* Jiejie Liu
* Jing Nie
* Weidong Han